Obecetrapib, CETP inhibition, and atherosclerosis: there is light at the end of the tunnel. [PDF]
Toth PP, Banach M.
europepmc +1 more source
Context-Dependent Effects of Apolipoprotein A2 on Lipid Metabolism and Atherogenesis. [PDF]
Zvintzou E +9 more
europepmc +1 more source
Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins. [PDF]
Brandts J +5 more
europepmc +1 more source
Selective Lipoprotein Removal Enables High-Purity EV Isolation from Plasma via Aptamer-Based Mesh Filtration. [PDF]
Jeon S, Kim Y, Shin S.
europepmc +1 more source
HDL Functionality and Lipoprotein Quality in Diabetes Mellitus
Background & AimsThe ‘high-density lipoprotein (HDL) hypothesis’, that therapeutic interventions directed at raising HDL cholesterol might translate into improved cardiovascular outcomes, has been confounded by recent reports from genetic and pharmacological studies. HDL functionality may be more important than cholesterol cargo. HDL cholesterol levels
openaire +1 more source
High-Density Lipoprotein-Specific Phospholipid Efflux (HDL-SPE) Assay in Mice. [PDF]
Sato M +4 more
europepmc +1 more source
HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading? [PDF]
Parini P, Pedrelli M.
europepmc +1 more source
Serum lipid alterations in oral squamous cell carcinoma and oral potentially malignant disorders: A systematic review and meta-analysis. [PDF]
Kishor S +3 more
europepmc +1 more source
Global Lipid Guidelines: More Aligned Than They Appear. [PDF]
Sethi Y, Mahajan K, Banach M.
europepmc +1 more source

